BOLD earnings: real EPS beat/miss history, analyst consensus Hold, P/E -1.01. Updated 2026-07-23.
Boundless Bio (BOLD) Research Hub
Boundless Bio (BOLD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.83 USD (-0.70%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.01, market cap 0.06B. This hub links to the full technical, earnings and options research available for BOLD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.83 USD (-0.70%) |
| 52-week range | 1.4 USD – 3.04 USD |
| Trend regime | Range |
| 14-day RSI | 45.6 (Neutral) |
| Trailing P/E | -1.01 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for BOLD
Covered Call on BOLD: how it works, illustrative setup around the real 2.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BOLD: how it works, illustrative setup around the real 2.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BOLD: how it works, illustrative setup around the real 2.83 USD price, max profit/loss, breakeven and when to use it. Educational.
BOLD technical analysis: range, last 2.83 USD, RSI 45.6, 52w range 1.4 USD–3.04 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BOLD in?
Boundless Bio (BOLD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BOLD in an uptrend or downtrend?
As of 2026-09-11, BOLD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BOLD's trailing P/E ratio?
BOLD's trailing P/E is -1.01, with a market cap of 0.06B. See the earnings research page for full valuation detail.